Matthew T. Menard

1 month ago | ejves.com | Jeffrey J. Siracuse |Endovascular Surgery |Alik Farber |Matthew T. Menard |Kenneth Rosenfield |Michael S. Conte | +8 more

aDivision of Vascular and Endovascular Surgery, Department of Surgery, Boston University Chobanian and Avedisian School of Medicine, Boston Medical Center, Boston, MA bDivision of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Boston, MA cSection of Vascular Medicine, Massachusetts General Hospital, Boston, MA dDivision of Vascular and Endovascular Surgery, University of California San Francisco, San Francisco, CA eDivision of Vascular and Endovascular Surgery, University of...

Dec 11, 2024 | ejves.com | Matthew T. Menard |Alik Farber |Gheorghe Doros |Emiliano Chisci |Leonardo C. Clavijo |Ahmed Kayssi | +7 more

Oct 4, 2023 | ejves.com | Jeffrey J. Siracuse |Endovascular Surgery |Matthew T. Menard |Michael S. Conte

Objective: Anticipated perioperative morbidity is an important factor for choosing a revascularization method for chronic limb-threatening ischemia (CLTI). Our goal was to assess systemic perioperative complications of patients treated with surgical and endovascular revascularization in the Best Endovascular vs Best Surgical Therapy in Patients with CLTI (BEST-CLI) trial.